Cancer Science 2017 is an international conference on the topics of the future direction of the Cancer Treatment. As the theme of the conference emphasises ‘Defining an Evolved Approach towards Cancer Treatment’, the Conference is an outstanding international forum to present and discuss progress in exploration, expansion, ideals, and applications of the topics related to the Cancer Science & Therapy.

In addition to the multidisciplinary talks, Keynote sessions, and lectures relevant to cancer science & therapy, the Cancer Science 2017 is a complete 3 day event with panel discussions, open Q & A to generate a prime learning knowledge between participants.

Scientific Session of the Conference includes:

Cancer Cell Biology

Cancer cells are typically defied by their capacity to divide uncontrollably. Cancerous tumors are malignant, which means they can spread into, or invade, nearby tissues. In addition, as these tumors grow, some cancer cells can break off and travel to distant places in the body through the blood or the lymph system and form new tumors far from the original tumor. Cancer cells arise from the body’s own tissues. Cancer Cell Biology includes the molecular, biochemical, and cell-based approaches to better understand cancer pathogenesis.

Related Conferences: Cancer Conferences | Oncology Conferences | Cancer Science Conferences

19th Euro Congress on Cancer Science & Therapy, July 17-19, 2017, Lisbon, Portugal; 16th Oncologists Meeting, April 24-25, 2017, Dubai, UAE; Oncology & Cancer Conference, May 25-27, 2017, Osaka, Japan; 25th World Cancer Conference, Oct 19-21, 2017, London, UK; 8^th Blood Cancer Conference, May 25-27, 2017 London, UK; 2nd Cancer Diagnostics Conference, May 8-10, 2017 Barcelona, Spain; World Cancer Congress (WCC-2017), May 19-21, Barcelona, Spain; European Cancer Congress, Jan 27-30 2017, Netherlands, Amsterdam; NCRI Cancer Conference, Nov 05-08, 2017, Liverpool, UK; Cancer & Tumour Immunology Conference, July 03-05, 2017, Bangkok, Thailand; Global Conference on Cancer Therapy, Aug 07-09 2017, Frankfurt, Germany; Pancreatic Cancer 2017, Jun 12-13 2017, London, UK; Immuno World 2017, Jan 18-20 2017, Miami, US

Organ-Defined Cancers

Cancer has a diversified nature in relation to the organ specificity. Cancer is a group of more than 100 diseases that develop across time in virtually any of the body’s tissues. Each type of cancer has its unique features; the basic processes that produce cancer are quite similar in all forms of the disease. Organ Specific Cancers are cancers named basing on the location of cancer in the body organ. The various types of cancers include Head & Neck Cancer, Lung Cancer, Skin Cancer, Breast Cancer, Bone Cancers, Ovarian Cancer etc.

Related Conferences: Cancer Conferences | Oncology Conferences | Cancer Science Conferences

19th Euro Congress on Cancer Science & Therapy, July 17-19, 2017, Lisbon, Portugal; 2^nd Neuro Oncology and Neurosurgery Conference, April 24-25, 2017 Dubai, UAE; 15^th World Cancer Convention, November 27-28, 2017 Dubai, UAE; 11^th Leukemia Conference, October 05-06, 2017, London, UK; Oncology & Cancer Conference, May 25-27, 2017, Osaka, Japan; 9th Molecular Cancer Biomarkers Conference, August 24-25, 2017, Birmingham, UK; Hematology & Oncology Conference, June 29-July 01, 2017, Bangkok, Thailand; EMBL Conference: Cancer Genomics, Heidelberg, Nov 05-08, 2017 Germany; 30th Annual Meeting Danish Association for Cancer Research, April 28, 2017, Denmark; Pancreatic Cancer 2017, Jun 12-13 2017, London, UK; Irish Association for Cancer Research Cancer Conference, February 22 – 24, 2017, Kilkenny, Ireland; 19th AEK  Cancer Congress, March 01- 03, 2017, Heidelberg, Germany

Cancer Metastasis

Metastasis is the spread of a cancer or other disease from one organ or part of the body to another without being directly connected with it. When cancer cells break away from a tumour, they can travel to other areas of the body through the bloodstream or the lymph system. The lungs, liver, brain, and bones are the most common metastasis locations from solid tumors. Treatment and survival is determined, to a great extent, by whether or not a cancer remains localized or spreads to other locations in the body.

Related Conferences: Cancer Conferences | Oncology Conferences | Cancer Science Conferences

19th Euro Congress on Cancer Science & Therapy, July 17-19, 2017, Lisbon, Portugal; 25th World Cancer Conference, Oct 19-21, 2017, London, UK; 15th World Cancer Convention, November 27-28, 2017 Dubai, UAE; Oncology Case Reports Meeting, Aug 29-31, 2017, London, UK; 2^nd Gynaecologic Oncology Congress, Aug 28-29, 2017, London, UK; 8^th Blood Cancer Conference, May 25-27, 2017 London, UK; 2nd Cancer Diagnostics Conference, May 8-10, 2017 Barcelona, Spain; Frontiers in Cancer Immunotherapy Conference, Feb 27–28 2017, New York City, USA; European Cancer Congress, Jan 27-30, 2017, Netherlands, Amsterdam; NCRI Cancer Conference, Nov 05-08, 2017, Liverpool, UK; 6th Breast Cancer Conference, Feb 17-19, 2017, Hong Kong, China; World Cancer Congress, October 01 – 04, 2018 Kuala Lumpur, Malaysia; World Cancer Congress (WCC-2017), May 19-21, Barcelona, Spain

Cancer Genetics

Cancer is a genetic disease—that is, cancer is caused by certain changes to genes that control the way our cells function, especially how they grow and divide.Genetic changes that increase cancer risk can be inherited from our parents if the changes are present in germ cells.Cancer-causing genetic changes can also be acquired during one’s lifetime, as the result of errors that occur as cells divide during a person’s lifetime or exposure to substances, such as certain chemicals in tobacco smoke, and radiation, such as ultraviolet rays from the sun, that damage DNA.Cancers that are not caused by inherited genetic mutations can sometimes appear to “run in families.”

Related Conferences: Cancer Conferences | Oncology Conferences | Cancer Science Conferences

19th Euro Congress on Cancer Science & Therapy, July 17-19, 2017, Lisbon, Portugal; 2^nd Neuro Oncology and Neurosurgery Conference, April 24-25, 2017 Dubai, UAE; 16th Oncologists Meeting, April 24-25, 2017, Dubai, UAE; 25th World Cancer Conference, Oct 19-21, 2017, London, UK; 15th World Cancer Convention, November 27-28, 2017 Dubai, UAE; Oncology & Cancer Summit, May 25-27, 2017, Osaka, Japan; 20^th Radiation Oncology Conference, August 28-29, 2017, Brussels, Belgium; Immuno World 2017,  Jan 18-20 Jan 2017, Miami, US;  World Cancer Leaders' Summit, November 13-15, 2017, Mexico City, Mexico; 30th Annual Meeting Danish Association for Cancer Research, 28 April 2017, Denmark; 19^th AEK Cancer Congress, March 01- 03 2017, Heidelberg, Germany; NCRI Cancer Conference, Nov 05-08, 2017, Liverpool, UK

Cancer & Tumour Immunology

Cancer immunology studies interactions between the immune system and cancer cells (also called tumors or malignancies). It is a field of research that aims to discover cancer immunotherapies to treat and retard progression of the disease. The immune response, including the recognition of cancer-specific antigens, forms the basis of targeted and tumour marker-based diagnostic tests. Understanding these interactions is important for the development of new therapies for cancer treatment. Also, certain cancers are caused due to viruses as well.

Related Conferences: Cancer Conferences | Oncology Conferences | Cancer Science Conferences

19th Euro Congress on Cancer Science & Therapy, July 17-19, 2017, Lisbon, Portugal; 10^th Cancer & Tumour Immunology Conference, July 03-05, 2017, Bangkok, Thailand; 2^nd Medical Imaging and Clinical Research Congress, Sep 11-12, 2017 Paris, France; World Immunology Congress, Dec 14-15, 2017 Dubai, UAE; 25th World Cancer Conference, Oct 19-21, 2017, London, UK; 16th Oncologists Meeting, April 24-25, 2017, Dubai, UAE; Frontiers in Cancer Immunotherapy, Feb 27–28 2017, New York City, USA; Global Conference on Cancer Therapy, Aug 07-09  2017, Frankfurt, Germany; Immuno-Oncology 360°,  Feb 01–03, 2017, New York, US; NCRI Cancer Conference, Nov 05-08, 2017, Liverpool, UK; Immuno World 2017, Jan 18-20 Jan 2017, Miami, US

Cancer: Genomics & Metabolomics

Cancer genomics is the study of the totality of DNA sequence and gene expression differences between tumour cells and normal host cells. It aims to understand the genetic basis of tumour cell proliferation and the evolution of the cancer genome under mutation and selection by the body environment, the immune system and therapeutic interventions. The metabolites within a cell or biological system are being used to analyze cancer metabolism on a system-wide scale, painting a broad picture of the altered pathways and their interactions with each other. Cancer metabolomics involves chemical analysis by a range of analytical platforms through targeted/untargeted approaches. The application of metabolomics towards cancer research has led to a renewed appreciation of metabolism in cancer development and progression.

Related Conferences: Cancer Conferences | Oncology Conferences | Cancer Science Conferences

19th Euro Congress on Cancer Science & Therapy, July 17-19, 2017, Lisbon, Portugal; 2^nd Neuro Oncology and Neurosurgery Conference, April 24-25, 2017 Dubai, UAE; 15^th World Cancer Convention, November 27-28, 2017 Dubai, UAE; 11^th Leukemia Conference, October 05-06, 2017, London, UK; Oncology & Cancer Conference, May 25-27, 2017, Osaka, Japan; 9^th Molecular Cancer Biomarkers Conference, August 24-25, 2017, Birmingham, UK; Hematology & Oncology Conference, June 29-July 01, 2017, Bangkok, Thailand; EMBL Conference: Cancer Genomics, Heidelberg, Nov 05-08, 2017 Germany; 30th Annual Meeting Danish Association for Cancer Research, April 28, 2017, Denmark; Pancreatic Cancer 2017, Jun 12-13 2017, London, UK; Irish Association for Cancer Research Cancer Conference, February 22 – 24, 2017, Kilkenny, Ireland; 19th AEK  Cancer Congress, March 01- 03, 2017, Heidelberg, Germany

Targeted Cancer Therapy

Targeted therapy is a newer type of cancer treatment that uses drugs or other substances to more precisely identify and attack cancer cells, usually while doing little damage to normal cells. Targeted therapy is a growing part of many cancer treatment regimens. Targeted therapy or molecularly targeted therapy is one of the major modalities of medical treatment (pharmacotherapy) for cancer. The Drugs work by targeting specific genes or proteins. These genes and proteins are found in cancer cells or in cells related to cancer growth, like blood vessel cells. As a form of molecular medicine, targeted therapy blocks the growth of cancer cells by interfering with specific targeted molecules needed for carcinogenesis and tumour growth, rather than by simply interfering with all rapidly dividing cells.

Related Conferences: Cancer Conferences | Oncology Conferences | Cancer Science Conferences

19th Euro Congress on Cancer Science & Therapy, July 17-19, 2017, Lisbon, Portugal; 16th Oncologists Meeting, April 24-25, 2017, Dubai, UAE; 25th World Cancer Conference, Oct 19-21, 2017, London, UK; 15th World Cancer Convention, November 27-28, 2017 Dubai, UAE; Oncology & Cancer Summit, May 25-27, 2017, Osaka, Japan; 20^th Radiation Oncology Conference, August 28-29, 2017, Brussels, Belgium; Immuno World 2017,  Jan 18-20 Jan 2017, Miami, US;  World Cancer Leaders' Summit, November 13-15, 2017, Mexico City, Mexico; 30th Annual Meeting Danish Association for Cancer Research, 28 April 2017, Denmark; 19^th AEK Cancer Congress, March 01- 03 2017, Heidelberg, Germany; NCRI Cancer Conference, Nov 05-08, 2017, Liverpool, UK

Stem Cell Therapy

Stem Cells and Tumours cancer cells also have the characteristic which is also associated with normal stems cells. Stem Cell Therapy is use to prevent the disease .The most common stem cells therapy is bone marrow transplant. Stems cells transplant is used to treatment of cancer like leukemia, multiple myeloma of lymphoma. Cord Blood Stem and Cancer  cord blood contains haematopoietic (blood) stem cell ,these cells make different types of cells like red blood cells white blood cells Haematopoietic stem cells, purified from bone marrow or blood, have long been used in stem cell treatments for leukaemia, blood and bone marrow disorders when chemotherapy is used .

Related Conferences: Cancer Conferences | Oncology Conferences | Cancer Science Conferences

19th Euro Congress on Cancer Science & Therapy, July 17-19, 2017, Lisbon, Portugal; 25th World Cancer Conference, Oct 19-21, 2017, London, UK; 15th World Cancer Convention, November 27-28, 2017 Dubai, UAE; Oncology Case Reports Meeting, Aug 29-31, 2017, London, UK; 2^nd Gynaecologic Oncology Congress, Aug 28-29, 2017, London, UK; 8^th Blood Cancer Conference, May 25-27, 2017 London, UK; 2nd Cancer Diagnostics Conference, May 8-10, 2017 Barcelona, Spain; Frontiers in Cancer Immunotherapy Conference, Feb 27–28 2017, New York City, USA; European Cancer Congress, Jan 27-30, 2017, Netherlands, Amsterdam; NCRI Cancer Conference, Nov 05-08, 2017, Liverpool, UK; 6th Breast Cancer Conference, Feb 17-19, 2017, Hong Kong, China; World Cancer Congress, October 01 – 04, 2018 Kuala Lumpur, Malaysia; World Cancer Congress (WCC-2017), May 19-21, Barcelona, Spain

Cancer Biomarkers

A cancer biomarker is an element or procedure that indicates the presence of cancer in the body. A biomarker may be any molecule released by presence a tumor or a specific indication of the body to the presence of cancer. Cancer biomarkers are usually biological molecules found in blood, other body fluids, or tissues that are a sign of a normal or abnormal process, or of a condition or disease.

Related Conferences: Cancer Conferences | Oncology Conferences | Cancer Science Conferences

19th Euro Congress on Cancer Science & Therapy, July 17-19, 2017, Lisbon, Portugal; 9^th Molecular Cancer Biomarkers Conference, August 24-25, 2017, Birmingham, UK;Oncology & Cancer Conference, May 25-27, 2017, Osaka, Japan; 25th World Cancer Conference, Oct 19-21, 2017, London, UK; 8^th Blood Cancer Conference, May 25-27, 2017 London, UK; 2nd Cancer Diagnostics Conference, May 8-10, 2017 Barcelona, Spain; World Cancer Congress (WCC-2017), May 19-21, Barcelona, Spain; European Cancer Congress, Jan 27-30 2017, Netherlands, Amsterdam; NCRI Cancer Conference, Nov 05-08, 2017, Liverpool, UK; Cancer & Tumour Immunology Conference, July 03-05, 2017, Bangkok, Thailand; Global Conference on Cancer Therapy, Aug 07-09 2017, Frankfurt, Germany; Pancreatic Cancer 2017, Jun 12-13 2017, London, UK; Immuno World 2017, Jan 18-20 2017, Miami, US

Cancer Therapy and Treatments

Cancer can be treated by different processes like Radiation Therapy; Bone Marrow Transplantation this therapy takes place in case of leukaemia lymphoma and myeloma. Hormone Replacement Therapy  wherein the patient, in the course of medical treatment, receives hormones, either to supplement a lack of naturally occurring hormones, or to substitute other hormones for naturally occurring hormones. Surgery and Laparoscopy describes the performance of surgical procedures with the assistance of a video camera and several thin instruments. Immunotherapy is a type of cancer treatment that helps immune system against fight cancer.

Related Conferences: Cancer Conferences | Oncology Conferences | Cancer Science Conferences

19th Euro Congress on Cancer Science & Therapy, July 17-19, 2017, Lisbon, Portugal; 16th Oncologists Meeting, April 24-25, 2017, Dubai, UAE; Oncology & Cancer Conference, May 25-27, 2017, Osaka, Japan; 25th World Cancer Conference, Oct 19-21, 2017, London, UK; 8^th Blood Cancer Conference, May 25-27, 2017 London, UK; 2nd Cancer Diagnostics Conference, May 8-10, 2017 Barcelona, Spain; World Cancer Congress (WCC-2017), May 19-21, Barcelona, Spain; European Cancer Congress, Jan 27-30 2017, Netherlands, Amsterdam; NCRI Cancer Conference, Nov 05-08, 2017, Liverpool, UK; Cancer & Tumour Immunology Conference, July 03-05, 2017, Bangkok, Thailand; Global Conference on Cancer Therapy, Aug 07-09 2017, Frankfurt, Germany; Pancreatic Cancer 2017, Jun 12-13 2017, London, UK; Immuno World 2017, Jan 18-20 2017, Miami, US

Alternative Medicine & Cancer 

Alternative medicine or complementary medicine are practices claimed to have the healing effects of medicine but are disproven, unproven, impossible to prove, or only harmful Alternative medicine consists of a wide variety of practices, products, and therapies—ranging from those that are biologically plausible but not well tested, to those with known harmful and toxic effects. An even greater proportion of cancer patients use “complementary” therapies along with mainstream cancer treatment.

Related Conferences: Cancer Conferences | Oncology Conferences | Cancer Science Conferences

19th Euro Congress on Cancer Science & Therapy, July 17-19, 2017, Lisbon, Portugal; 15^th World Cancer Convention, November 27-28, 2017 Dubai, UAE; Oncology & Cancer Conference, May 25-27, 2017, Osaka, Japan; 25th World Cancer Conference, Oct 19-21, 2017, London, UK; 8^th Blood Cancer Conference, May 25-27, 2017 London, UK; 2nd Cancer Diagnostics Conference, May 8-10, 2017 Barcelona, Spain; World Cancer Congress (WCC-2017), May 19-21, Barcelona, Spain; European Cancer Congress, Jan 27-30 2017, Netherlands, Amsterdam; NCRI Cancer Conference, Nov 05-08, 2017, Liverpool, UK; Cancer & Tumour Immunology Conference, July 03-05, 2017, Bangkok, Thailand; Global Conference on Cancer Therapy, Aug 07-09 2017, Frankfurt, Germany; Pancreatic Cancer 2017, Jun 12-13 2017, London, UK; Immuno World 2017, Jan 18-20 2017, Miami, US

Cancer Case Reports

A case report signifies the detailed report of symptoms, signs, diagnosis, treatment, and follow-up of an individual patient of a particular disease. Cancer Case reports have been playing a pivotal role in medical education, providing a structure for case-based learning and implementation throughout the world.

Related Conferences: Cancer Conferences | Oncology Conferences | Cancer Science Conferences

19th Euro Congress on Cancer Science & Therapy, July 17-19, 2017, Lisbon, Portugal; 16th Oncologists Meeting, April 24-25, 2017, Dubai, UAE; Oncology & Cancer Conference, May 25-27, 2017, Osaka, Japan; 25th World Cancer Conference, Oct 19-21, 2017, London, UK; 8^th Blood Cancer Conference, May 25-27, 2017 London, UK; 2nd Cancer Diagnostics Conference, May 8-10, 2017 Barcelona, Spain; World Cancer Congress (WCC-2017), May 19-21, Barcelona, Spain; European Cancer Congress, Jan 27-30 2017, Netherlands, Amsterdam; NCRI Cancer Conference, Nov 05-08, 2017, Liverpool, UK; Cancer & Tumour Immunology Conference, July 03-05, 2017, Bangkok, Thailand; Global Conference on Cancer Therapy, Aug 07-09 2017, Frankfurt, Germany; Pancreatic Cancer 2017, Jun 12-13 2017, London, UK; Immuno World 2017, Jan 18-20 2017, Miami, US

Novel Approaches to Cancer Therapeutics

The Normal treatment modalities are associated with severe side effects and high toxicity which in turn lead to low quality of life. This review encompasses novel strategies for more effective chemotherapeutic delivery aiming to generate better prognosis. Currently, cancer treatment is a highly dynamic field and significant advances are being made in the development of novel cancer treatment strategies. In contrast to conventional cancer therapeutics, novel approaches such as ligand or receptor based targeting, intracellular drug targeting, gene delivery, cancer stem cell therapy, magnetic drug targeting and ultrasound-mediated drug delivery, have added new modalities for cancer treatment.

Related Conferences: Cancer Conferences | Oncology Conferences | Cancer Science Conferences

19th Euro Congress on Cancer Science & Therapy, July 17-19, 2017, Lisbon, Portugal; 25th World Cancer Conference, Oct 19-21, 2017, London, UK; 16th Oncologists Meeting, April 24-25, 2017, Dubai, UAE; Oncology & Cancer Conference, May 25-27, 2017, Osaka, Japan; 8^th Blood Cancer Conference, May 25-27, 2017 London, UK; 2nd Cancer Diagnostics Conference, May 8-10, 2017 Barcelona, Spain; World Cancer Congress (WCC-2017), May 19-21, Barcelona, Spain; European Cancer Congress, Jan 27-30 2017, Netherlands, Amsterdam; NCRI Cancer Conference, Nov 05-08, 2017, Liverpool, UK; Cancer & Tumour Immunology Conference, July 03-05, 2017, Bangkok, Thailand; Global Conference on Cancer Therapy, Aug 07-09 2017, Frankfurt, Germany; Pancreatic Cancer 2017, Jun 12-13 2017, London, UK; Immuno World 2017, Jan 18-20 2017, Miami, US

Precision Medicine & Cancer Therapy

Precision medicine also known as Personalised Medicine is a phrase that is often used to describe how genetic information about a person’s disease is being used to diagnose or treat their disease. The deeper understanding of how cancer forms and grows has ushered in a new era of precision cancer care, where tailored treatments target abnormalities that may be found in each tumor’s DNA profile. This exciting innovation marks a shift, from traditional treatments designed for the average patient based on their success with a representative sample of people with similar cancers, toward more precise therapies.

Related Conferences: Cancer Conferences | Oncology Conferences | Cancer Science Conferences

19th Euro Congress on Cancer Science & Therapy, July 17-19, 2017, Lisbon, Portugal; 16th Oncologists Meeting, April 24-25, 2017, Dubai, UAE; Oncology & Cancer Conference, May 25-27, 2017, Osaka, Japan; 25th World Cancer Conference, Oct 19-21, 2017, London, UK; 8^th Blood Cancer Conference, May 25-27, 2017 London, UK; 2nd Cancer Diagnostics Conference, May 8-10, 2017 Barcelona, Spain; World Cancer Congress (WCC-2017), May 19-21, Barcelona, Spain; European Cancer Congress, Jan 27-30 2017, Netherlands, Amsterdam; NCRI Cancer Conference, Nov 05-08, 2017, Liverpool, UK; Cancer & Tumour Immunology Conference, July 03-05, 2017, Bangkok, Thailand; Global Conference on Cancer Therapy, Aug 07-09 2017, Frankfurt, Germany; Pancreatic Cancer 2017, Jun 12-13 2017, London, UK; Immuno World 2017, Jan 18-20 2017, Miami, US

Cancer Management & Prevention

Cancers that are closely linked to certain behaviours are the easiest to prevent. Many complementary health approaches are also there to combat the risks of cancers like—for example, herbal and other dietary supplements, acupuncture, massage, and yoga.

Related Conferences: Cancer Conferences | Oncology Conferences | Cancer Science Conferences

19th Euro Congress on Cancer Science & Therapy, July 17-19, 2017, Lisbon, Portugal; 15^th World Cancer Convention, November 27-28, 2017 Dubai, UAE;; Oncology & Cancer Conference, May 25-27, 2017, Osaka, Japan; 25th World Cancer Conference, Oct 19-21, 2017, London, UK; 8^th Blood Cancer Conference, May 25-27, 2017 London, UK; 2nd Cancer Diagnostics Conference, May 8-10, 2017 Barcelona, Spain; World Cancer Congress (WCC-2017), May 19-21, Barcelona, Spain; European Cancer Congress, Jan 27-30 2017, Netherlands, Amsterdam; NCRI Cancer Conference, Nov 05-08, 2017, Liverpool, UK; Cancer & Tumour Immunology Conference, July 03-05, 2017, Bangkok, Thailand; Global Conference on Cancer Therapy, Aug 07-09 2017, Frankfurt, Germany; 19^th World Congress of Psycho-Oncology and Psychosocial Academy, 14 Aug 2017 - 18 Aug 2017, Berlin, Germany; Immuno World 2017, Jan 18-20 2017, Miami, US

Cancer Pharmacology

Cancer pharmacology plays a key role in drug development. In both the laboratory and the clinic, cancer pharmacology has had to adapt to the changing face of drug development by establishing experimental models and target orientated approaches.

Related Conferences: Cancer Conferences | Oncology Conferences | Cancer Science Conferences

19th Euro Congress on Cancer Science & Therapy, July 17-19, 2017, Lisbon, Portugal; 16^th Oncologists Meeting, April 24-25, 2017, Dubai, UAE; Oncology & Cancer Conference, May 25-27, 2017, Osaka, Japan; 25th World Cancer Conference, Oct 19-21, 2017, London, UK; 8^th Blood Cancer Conference, May 25-27, 2017 London, UK; 2nd Cancer Diagnostics Conference, May 8-10, 2017 Barcelona, Spain; World Cancer Congress (WCC-2017), May 19-21, Barcelona, Spain; European Cancer Congress, Jan 27-30 2017, Netherlands, Amsterdam; NCRI Cancer Conference, Nov 05-08, 2017, Liverpool, UK; Cancer & Tumour Immunology Conference, July 03-05, 2017, Bangkok, Thailand; Global Conference on Cancer Therapy, Aug 07-09 2017, Frankfurt, Germany; Pancreatic Cancer 2017, Jun 12-13 2017, London, UK; Immuno World 2017, Jan 18-20 2017, Miami, US

Summary

Cancer is the second leading cause of death worldwide and in all regions of the world. It has undergone a period of dramatic economic, social, and demographic change, resulting in increased life expectancy and prosperity. Cancer is when abnormal cells divide in an uncontrolled way. Some cancers may eventually spread into other tissues. There are more than 200 different types of cancer.

Importance & Scope

It’s crucial to remember that cancer is not one disease – it’s more than 200 cancer diseases involved. All different, unique diseases, which require different approaches for treatment. Treatments that work for some cancers don’t work for others and sometimes those treatments simply stop working. Only worldwide research will enhance our understanding of cancer and help us find and develop better, more effective treatments. And only a global search for answers will help us get to grips with this disease. . The conference will provide with an exceptional opportunity for the delegates from Universities and Institutes to interact with the world class Scientists and Industry Professionals working in the field of cancer/oncology. The conference will provide with an exceptional opportunity for the delegates from Universities and Institutes to interact with the world class Scientists and Industry Professionals working in the field of cancer/oncology.

Cancer Science 2017 will also explore the new ideas and concepts on global scale and the topics Cancer Science & Therapy, Cancer Cell Biology, Organ-Defined Cancers, Tumour Science, Cancer Genetics, Clinical Cancer Research, Cancer & Tumour Immunology, Cancer : Genomics & Metabolomics, Targeted Cancer Therapy, Stem Cell Therapy, Cancer Biomarkers, Cancer Treatment & Therapeutics, Cancer Clinical Trials, Cancer Case Reports, Cancer Drug Diagnostics & Therapeutics, Frontiers in Cancer Science, Precision Medicine & Cancer Therapy, Cancer Management & Prevention, Economic Impact of Cancer Therapy.

For More details please visit: http://cancerscience.conferenceseries.com/

Why Lisbon?

Lisbon is the continental Europe's westernmost capital city. A leading Cancer Center in Portugal became the first in world to Edge™ Radiosurgery. Lisbon and its heavily populated surroundings are also developing as an important financial centre and a dynamic technological hub. It is also s recognised as a global city because of its importance in finance, commerce, media, entertainment, arts, international trade, education and tourism. Due to the advancements in the field of cancer research in Lisbon, it is been seen as the apt destination for the conference.

Brief Report of Market on Cancer Research

There are recent advancements in the cancer treatments & cancer care is accelerating. A cluster of innovative treatments, often combined with other new or existing medicines, and frequently associated with biomarkers, are emerging from the research and development pipeline.Over the past five years, 70 new oncology treatments have been launched and are being used to treat over 20 different tumour types.

The global cancer immunotherapies market reached $30.8 billion in 2012. This market is expected to grow to nearly $34.3 billion in 2013 and $67.9 billion in 2018 with a compound annual growth rate (CAGR) of 14.7% over the five-year period, 2013 to 2018. This report   includes discussion of the regulatory environment, current and developing technologies, cancer incidence, market projections and market share, along with latest trends and clinical trials.

Figure 1: Global Cancer Immunotherapies Market (2012-2018)

The total cost of cancer therapeutics and medicines used in supportive care– measured at the ex-manufacturer price level before the application of rebates or other price concessions – reached $107 billion in 2015, representing an increase in constant dollars of 11.5% over the prior year

Annual global growth in the oncology drug market is expected to be 7.5 – 10.5 % through 2020, reaching $150 billion. Wider utilization of new products—especially immunotherapies—will drive much of the growth, offset by reduced use of some existing treatments with inferior clinical outcomes.

The global market for biologic cancer treatment totalled about $51.2 billion in 2014 and is expected to reach $66.4 billion in 2019, registering a compound annual growth rate (CAGR) of 5.4% for the period 2014-2019. It includes current issues and trends affecting the industry, costs and factors influencing demand. The report covers biological products in development, biological products in clinical trials, and currently marketed and late-stage development biologic cancer products.

Figure 2: Global Market for Biologic Cancer Treatment(2014-2019)

Major Medical Universities 

Worldwide

• Harvard University
• University of Minnesota
• Mayo Medical School
• Pittsburgh School of Medicine
• Yale University
• University of Cambridge
• University of Oxford Stanford University
• Yale University
• Emory University
• John Hopkins University
• Kings College London
• Feinberg School of Medicine
• University of Wisconsin
• UNC School of Medicine
• Karolinska University

In Europe

• University of Sheffield
• University of Manchester
• University of Lisbon
• King's College London
• Newcastle University
• University of Nottingham
• University of Glasgow
• University of Milan
• University of Cambridge
• University of Bristol
• University of Aberdeen
• Virginia Cancer Institute
• University of Warwick
• University of Oxford
• University of Edinburgh
• Sapienza Universita Di Roma
• Durham University
• Cardiff University

Major Associations

Worldwide

• American Association for Cancer Research
• Virginia Cancer Institute
• American Brain Tumor Association
• American Society of Pediatric Hematology/Oncology
• Association of Cancer Physicians
• American Childhood Cancer Organization
• American Society of Clinical Oncology
• Australasian Lung Cancer Trials Group
• International Cancer Research Partnership (ICRP)
• American Association for Cancer Research (AACR)
• American Society of Clinical Oncology (ASCO)
• International Agency for Research on Cancer (IARC)
• Cancer Society of New Zealand
• Irish Cancer Society
• Australian Cervical Cancer Foundation
• Medical Centre Cologne
• Cancer Research UK
• Australian Prostate Cancer Research
• Peter McCollum Cancer Centre
• The European Cancer Organization (ECCO)
• German Cancer Research Centre

In Europe

• Association of Cancer Physicians
• British Gynaecological Cancer Society
• Children with Cancer UK
• United Kingdom Association of Cancer Registries
• Prostate Cancer UK
• UK Oncology Nursing Children’s Cancer and Leukaemia Group Society
• Childhood Cancer Research Group Cancer Focus BASO
• The Association for Cancer Surgery
• Northern Ireland Cancer Research UK

Top Centres & Hospitals in Portugal

• Portuguese Institute of Oncology Francisco Gentil of Coimbra,
• Portugal Portuguese Institute of Oncology Francisco Gentil in Lisbon
• Portugal Portuguese Institute of Oncology Francisco Gentil Port
• Portugal Liga Portuguesa Contra o Cancro |
• Portuguese Cancer League - Português
• Europe Portugal - European Cancer Observatory
• Hospital Lisbon Central
• Santo Antonio General Hospital
• Portuguese Institute of Oncology of Lisbon
• Bonfim Central Clinic Ltd.
• Hospital Center in the western Algarve
• Jose de Mello Health Group
• Braga Hospital
• Hospital da Luz